THEA-MONOPROST EYE DROPS 30 UD

•  Monopost contains latanoprost 50 µg/ml in a preservative-free, single-dose eye drop formulation¹
•  Latanoprost is a selective prostanoid FP receptor agonist which reduces intraocular pressure (IOP) by increasing the outflow of aqueous humour¹

Monopost is indicated for the reduction of elevated IOP in patients with open angle glaucoma and ocular hypertension. It reduces the risk of ocular surface problems that have been reported to be caused by long-term use of preservative-containing eye drops.^2,3

Monopost has been shown to provide non-inferior IOP control compared to Xalatan, with statistically significantly lower hyperaemia and symptoms on instillation.²

Studies where patients have been switched from preserved latanoprost to Monopost have demonstrated reductions in the frequency and severity of hyperaemia and other symptoms